DM-235 · Evidence-based safety and harm-reduction overview.
| Also known as | DM-235 |
| Category | Nootropic |
| controlled_status | Unscheduled US (unapproved) |
| approval_status | Not FDA-approved; never entered human trials |
| research_stage | Preclinical only; no human data |
| US legal status | Sunifiram is an experimental research chemical that is not FDA-approved and not authorized for human consumption in the United States. It is sold online in an unregulated gray market and has not been evaluated for safety or efficacy in people. |
Sunifiram is a synthetic compound loosely related to the piracetam family of nootropics, though structurally distinct. It has been studied only in preclinical settings as a potential cognition-modulating agent.
Research in animal models suggests sunifiram acts on AMPA receptors, enhancing calcium flux and synaptic transmission. Studies also indicate possible effects on protein kinase C and other intracellular signaling pathways implicated in memory formation, though human mechanisms are entirely unknown.
Sunifiram was synthesized as a research compound in the 1990s as part of the racetam-related compound family but diverged structurally. It has undergone only preclinical investigation and has never reached human clinical trials, making it a purely experimental agent.
Research on sunifiram is almost entirely preclinical, with animal and laboratory studies reporting effects on AMPA receptors and memory-related signaling. Studies suggest potential cognitive activity in rodents, but there are essentially no controlled human trials, so human efficacy and safety are unknown.
Animal studies have used doses in the range of 1-10 mg/kg, but there is no established human dose and no data to guide dosing in people. Anecdotal online reports mention doses from 100 mg to several grams, but these lack any scientific basis.
This is general research/context information, not medical advice or a recommended protocol.
Sunifiram should never be combined with other compounds due to complete absence of safety and interaction data. Any such use would be entirely experimental and high-risk.
If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsIts safety in humans is unknown because there are no controlled human studies; any use is experimental.
It is unapproved and sold in an unregulated gray market, not authorized for human consumption.
We do not provide dosing guidance, and there is no established human dose. Consult a qualified clinician.
No. All available research is in animal or in vitro models; it has never advanced to human clinical trials.
It remains purely a research chemical. It has not been developed for human use and remains experimental with no pathway toward medical approval.
AMPA receptor activation carries theoretical seizure risk in animals; this has never been tested in humans and represents an unknown danger.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.